Type 2 Diabetes: Treat-to-Target Slideshows


These presentations by Laurence Hirsch, MD are based on the 2009 updated consensus algorithm for the treatment of type 2 diabetes, developed by the American Diabetes association and the European Association for the Study of Diabetes.

The presentations describe the rationale for rapid, continuously adjusted treatment of type 2 diabetes- this is called "treat to target."

The newest oral and injected therapies are discussed, along with a useful way to classify patients according to their A1c and other glycemic measures.

Safety, efficacy and patient ratings of a new
4mm x 32g pen needle protocol

Shaking it up: new findings in injection therapy and what that means for diabetes best practice

Use of oral agents and incretins in type 2 diabetes

Use of insulin in type 2 diabetes

Premixed insulin regimens for type 2 diabetes

 



Important Note: The content of this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Do not disregard your doctor's advice or delay in seeking it because of something you have read in this website.

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2013 BD